Neucure Lifesciences Private Limited
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Glimzab MV 1mg/500mg/0.3mg Tablet is a combination of medicines used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet
Glimzab MV 1mg/500mg/0.3mg Tablet is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes. Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Carry a sugar source with you for immediate relief.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Glimzab MV 1mg/500mg/0.3mg Tablet is to be taken empty stomach.
Glimzab MV 1mg/500mg/0.3mg Tablet is a combination of three antidiabetic medicines.
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Glimzab MV 1mg/500mg/0.3mg Tablet is a combination of three medications: Glimepiride, Metformin and Voglibose. This medication is used in the treatment of type 2 diabetes mellitus (DM). It improves blood glucose levels in adults when taken with proper diet and regular exercise. Glimepiride lowers blood glucose by increasing insulin release from the pancreas. Metformin works by lowering glucose production in the liver and improving insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that lowers postprandial (after meals) glucose levels. This combination is not indicated for type 1 diabetes treatment.
Common side effects of Glimzab MV 1mg/500mg/0.3mg Tablet include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection.
Avoid using this medication if you have known allergies to any of the components or excipients in the medication, or are experiencing moderate to severe kidney disease. It is also advised against taking this medication in patients with inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis including diabetic ketoacidosis.
No, combining Glimzab MV 1mg/500mg/0.3mg Tablet with alcohol is not advised as it may worsen low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Yes, Glimzab MV 1mg/500mg/0.3mg Tablet can cause hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. This is more likely to occur if you miss meals, drink alcohol, over-exercise, or take other diabetes medications along with it. Regular monitoring of your blood sugar levels is essential. Always keep glucose tablets, honey, or fruit juice on hand in case of sudden blood sugar drops.
Store this medication in its original packaging, tightly closed. Refer to the label on the packaging or container for storage instructions. Do not dispose of the unused medication. Keep it away from pets and children, as well as unauthorized individuals.